Arachidonic acid activation of translation initiation signaling in vascular smooth muscle cells

Biochemical and Biophysical Research Communications

Volumn 309, Issue 4, 2003, Pages 755-761

  Neeli, Indira ^a   Yellaturu, Chandrahasa R ^a   Rao, Gadiparthi N ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Arachidonic acid; Cyclooxygenase; Eukaryotic initiation factor 4E; Lipoxygenase; Phosphatidylinositol 3 kinase; Protein synthesis; Ribosomal protein S6 kinase1; Vascular smooth muscle cells

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; ARACHIDONIC ACID; INITIATION FACTOR 4E; LIPOXYGENASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROSTAGLANDIN SYNTHASE; PROTEIN KINASE B; RIBOSOMAL PROTEIN S6 KINASE 1; RIBOSOME PROTEIN; SATURATED FATTY ACID; UNCLASSIFIED DRUG; UNSATURATED FATTY ACID; UNSPECIFIC MONOOXYGENASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; MALE; METABOLISM; MUSCLE CELL; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN SYNTHESIS; RAT; SIGNAL TRANSDUCTION; THORACIC AORTA; TRANSLATION INITIATION; VASCULAR SMOOTH MUSCLE;

EUKARYOTA;

EID: 0141564945     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.08.066     Document Type: Article

References (53)

1. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
2. Touqui L., Alaoui-El-Azher M. Mammalian secreted phospholipases A2 and their pathophysiological significance in inflammatory diseases. Curr. Mol. Med. 1:2001;739-754.
3. Hurt-Camejo E., Anderson S., Standal R., Rosengren B., Sartipy P., Stadberh E., Johansen B. Localization of nonpancreatic secretory phospholipaseA2 in normal and atherosclerotic arteries: activity of the isolated enzyme on low-density lipoproteins. Arterioscler. Thromb. Vasc. Biol. 17:1997;300-309.
4. Ivandic B., Castellani L.W., Wang X.P., Qiao J.H., Mehrabian M., Navab M., Fogelman A.M., Grass D.S., Swanson M.E., de Beer M.C., de Beer F., Lusis A.J. Role of group II secretory phospholipase A2 in atherosclerosis: 1. Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2. Arterioscler. Thromb. Vasc. Biol. 19:1999;1284-1290.
5. Mallat Z., Nakamura T., Ohan J., Leseche G., Tedgui A., Maclouf J., Murphy R.C. The relationship of hydroxyeicosatetraenoic acids and F2-isoprostanes to plaque instability in human carotid atherosclerosis. J. Clin. Invest. 103:1999;421-427.
6. Dennis E.A. Diversity of group types, regulation, and function of phospholipase A2. J. Biol. Chem. 269:1994;13057-13060.
7. Leslie C.C. Properties and regulation of cytosolic phospholipase A2. J. Biol. Chem. 272:1997;16709-16712.
8. Piomelli D. Arachidonic acid in cell signaling. Curr. Opin. Cell. Biol. 5:1993;274-280.
9. Dethlefsen S.M., Shepro D., D'Amore P.A. Arachidonic acid metabolites in bFGF-, PDGF, and serum-stimulated vascular cell growth. Exp. Cell Res. 212:1994;262-273.
10. Gronich J., Konieczkowski M., Gelb M.H., Nemenoff R.A., Sedor J.R. Interleukin 1 alpha causes rapid activation of cytosolic phospholipase A2 by phosphorylation in rat mesangial cells. J. Clin. Invest. 93:1994;1224-1233.
11. Rao G.N., Lassegue B., Alexander R.W., Griendling K.K. Angiotensin II stimulates phosphorylation of high-molecular-mass cytosolic phospholipase A2 in vascular smooth-muscle cells. Biochem. J. 299:1994;197-201.
12. Xing M., Firestein B.L., Shen G.H., Insel P.A. Dual role of protein kinase C in the regulation of cPLA2-mediated arachidonic acid release by P2U receptors in MDCK-D1 cells: involvement of MAP kinase-dependent and -independent pathways. J. Clin. Invest. 99:1997;805-814.
13. Goetzl E.J., An S., Smith W.L. Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases. FASEB J. 9:1995;1051-1058.
14. Lin L., Balazy M., Pagano P.J., Nasjletti A. Expression of prostaglandin H2-mediated mechanism of vascular contraction in hypertensive rats. Relation to lipoxygenase and prostacyclin synthase activities. Circ. Res. 74:1994;197-205.
15. Pfister S.L., Spitzbarth N., Nithipatkom K., Edgemond W.S., Falck J.R., Campbell W.B. Identification of the 11,14,15- and 11,12,15-trihydroxyeicosatrienoic acids as endothelium-derived relaxing factors of rabbit aorta. J. Biol. Chem. 273:1998;30879-30887.
16. Sellmayer A., Vedelhoven W.M., Weber P.C., Bonventre J.V. Endogenous non-cyclooxygenase metabolites of arachidonic acid modulate growth and mRNA levels of immediate-early response genes in rat mesangial cells. J. Biol. Chem. 266:1991;3800-3807.
17. Glasgow W.C., Afshari C.A., Barrett J.C., Eling T.E. Modulation of the epidermal growth factor mitogenic response by metabolites of linoleic and arachidonic acid in Syrian hamster embryo fibroblasts. Differential effects in tumor suppressor gene (+) and (-) phenotypes. J. Biol. Chem. 267:1992;10771-10779.
18. Tang D.G., Chen Y.Q., Honn K.V. Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis. Proc. Natl. Acad. Sci. USA. 93:1996;5241-5246.
19. Chen J.K., Capdevila J., Harris R.C. Cytochrome p450 epoxygenase metabolism of arachidonic acid inhibits apoptosis. Mol. Cell. Biol. 21:2001;6322-6331.
20. Mezentsev A., Seta F., Dunn M.W., Ono N., Falck J.R., Schwartzman M.L. Eicosanoid regulation of vascular endothelial growth factor expression and angiogenesis in microvessel endothelial cells. J. Biol. Chem. 277:2002;18670-18676.
21. Panini S.R., Yang L., Rusinol A.E., Sinensky M.S., Bonventre J.V., Leslie C.C. Arachidonate metabolism and the signaling pathway of induction of apoptosis by oxidized LDL/oxysterol. J. Lipid Res. 42:2001;1678-1686.
22. Fafeur V., Jiang Z.P., Bohlen P. Signal transduction by bFGF, but not TGF beta 1, involves arachidonic acid metabolism in endothelial cells. J. Cell. Physiol. 149:1991;277-283.
23. Golubic M., Tanaka K., Dobrowolski S., Wood D., Tsai M.H., Marshall M., Tamanoi F., Stacey D.W. The GTPase stimulatory activities of the neurofibromatosis type 1 and the yeast IRA2 proteins are inhibited by arachidonic acid. EMBO J. 10:1991;2897-2903.
24. Tsai M.H., Roudebush M., Dobrowolski S., Yu C.L., Gibbs J.B., Stacey D.W. Ras GTPase-activating protein physically associates with mitogenically active phospholipids. Mol. Cell. Biol. 11:1991;2785-2793.
25. Peppelenbosch M.P., Tertoolen L.G., Hage W.J., deLaat S.W. Epidermal growth factor-induced actin remodeling is regulated by 5-lipoxygenase and cyclooxygenase products. Cell. 74:1993;565-575.
26. Rao G.N., Baas A.S., Glasgow W.C., Eling T.E., Runge M.S., Alexander R.W. Activation of mitogen-activated protein kinases by arachidonic acid and its metabolites in vascular smooth muscle cells. J. Biol. Chem. 269:1994; 32586-32591.
27. 2+ pool depletion. J. Biol. Chem. 271:1996;883-888.
28. Hershey J.W.B., Merrick W.C. Pathway and mechanism of initiation of protein synthesis. Sonenberg N., Hershey J.W.B., Mathews M.B. Translational Control of Gene Expression. 2000;33-88 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
29. Gingras A.C., Raught B., Sonenberg N. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68:1999;913-963.
30. Rhoads R.E. Signal transduction pathways that regulate eukaryotic protein synthesis. J. Biol. Chem. 274:1999;30337-30340.
31. Rozen F., Edery I., Meerovitch K., Dever T.E., Merrick W.C., Sonenberg N. Bidirectional RNA helicase activity of eucaryotic translation initiation factors 4A and 4F. Mol. Cell. Biol. 10:1990;1134-1144.
32. Hentze M.W. eIF4G: a multipurpose ribosome adapter? Science. 275:1997;500-501.
33. Gingras A.C., Kennedy S.G., Oleary M.A., Sonenberg N., Hay N. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev. 12:1998;502-513.
34. Mothe-Satney I., Yang D., Fadden P., Haystead T.A., Lawrence J.C. Jr. Multiple mechanisms control phosphorylation of PHAS-I in five (S/T)P sites that govern translational repression. Mol. Cell. Biol. 20:2000;3558-3567.
35. Scheper G.C., Morrice N.A., Kleijn M., Proud C.G. The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells. Mol. Cell. Biol. 21:2001;743-754.
36. Fukunaga R., Hunter T. MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates. EMBO J. 16:1997;1921-1933.
37. Waskiewicz A.J., Flynn A., Proud C.G., Cooper J.A. Mitogen-activated protein kinases activate the serine/threonine kinases Mnk1 and Mnk2. EMBO J. 16:1997;1909-1920.
38. Fruman D.A., Meyers R.E., Cantley L.C. Phosphoinositide kinases. Annu. Rev. Biochem. 67:1998;481-507.
39. Fingar D.C., Salama S., Tsou C., Harlow E., Blenis J. Mammalian cell size is controlled by mTOR and its downstream targets S6K1 and 4EBP1/eIF4E. Genes Dev. 16:2002;1472-1487.
40. von Manteuffel S.R., Dennis P.B., Pullen N., Gingras A.C., Sonenberg N., Thomas G. The insulin-induced signalling pathway leading to S6 and initiation factor 4E binding protein 1 phosphorylation bifurcates at a rapamycin-sensitive point immediately upstream of p70s6k. Mol. Cell. Biol. 17:1997;5426-5436.
41. Fumagali S., Thomas G. S6 phosphorylation and signal transduction. Sonenberg N., Hershey J.W.B., Mathews M.B. Translational Control of Gene Expression. 2000;695-718 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
42. Rao G.N., Madamanchi N.R., Lele M., Gadiparthi L., Gingras A.C., Eling T.E., Sonenberg N. A potential role for extracellular signal-regulated kinases in prostaglandin F2alpha-induced protein synthesis in smooth muscle cells. J. Biol. Chem. 274:1999;12925-12932.
43. Orning L., Hammarstrom S. Inhibition of leukotriene C and leukotriene D biosynthesis. J. Biol. Chem. 255:1980;8023-8026.
44. Meade E.A., Smith W.L., DeWitt D.L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268:1993;6610-6614.
45. 2 in angiotensin II-induced hypertrophy. J. Biol. Chem. 275:2000;16993-16999.
46. Duncan R.F., Peterson H., Hagedorn C.H., Sevanian A. Oxidative stress increases eukaryotic initiation factor 4E phosphorylation in vascular cells. Biochem J. 369:2003;213-225.
47. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269:1994;5241-5248.
48. Bierer B.E., Mattila P.S., Standaert R.F., Herzenberg L.A., Burakoff S.J., Crabtree G., Schreiber S.L. Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin. Proc. Natl. Acad. Sci. USA. 87:1990;9231-9235.
49. Bodine S.C., Stitt T.N., Gonzalez M., Kline W.O., Stover G.L., Bauerlein R., Zlotcenko E., Scrimgeour A., Lawrence J.C. Jr., Glass D.J. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat. Cell. Biol. 3:2001;1014-1019.
50. Lachance P.E., Miron M., Raught B., Sonenberg N., Lasko P. Phosphorylation of eukaryotic translation initiation factor 4E is critical for growth. Mol. Cell. Biol. 22:2002;1656-1663.
51. Brunn G.J., Williams J., Sabers C., Wiederrecht G., Lawrence J.C. Jr., Abraham R.T. Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J. 15:1996;5256-5267.
52. Herbert T.P., Kilhams G.R., Batty I.H., Proud C.G. Distinct signalling pathways mediate insulin and phorbol ester-stimulated eukaryotic initiation factor 4F assembly and protein synthesis in HEK 293 cells. J. Biol. Chem. 275:2000;11249-11256.
53. Madamanchi N.R., Bukoski R.D., Runge M.S., Rao G.N. Arachidonic acid activates Jun N-terminal kinase in vascular smooth muscle cells. Oncogene. 16:1998;417-422.